Better Fitness Cuts Mortality Risk by 67% in Kidney Disease Patients
A massive 45,000-patient study reveals that higher cardiorespiratory fitness dramatically lowers death risk in chronic kidney disease.
Summary
A prospective study of 45,674 US veterans with chronic kidney disease (CKD) found that better cardiorespiratory fitness (CRF), measured by treadmill testing, was strongly linked to lower mortality. Over nearly 16 years, 53% of participants died. Each one-MET improvement in fitness reduced mortality risk by 12%. Compared to the least-fit patients, the fittest group had a 67% lower risk of death. Crucially, this protective pattern held across all ages, races, and sexes. The findings suggest that improving physical fitness should be a central therapeutic target in CKD management, potentially offering one of the most powerful tools available to extend survival in this high-risk population.
Detailed Summary
Chronic kidney disease affects hundreds of millions globally and carries a dramatically elevated risk of early death. Despite growing evidence that physical fitness protects against mortality in the general population, data specifically focused on CKD patients remained limited — until now.
Researchers analyzed data from 45,674 men and women with CKD drawn from the ETHOS (Exercise Testing and Health Outcomes) study, a large Veterans Affairs cohort of over 750,000 individuals. All participants completed a standardized exercise treadmill test to objectively measure cardiorespiratory fitness in metabolic equivalents (METs). They were then followed for an average of nearly 16 years, during which over half — 53.2% — died.
The results were striking. Every single one-MET increase in fitness was associated with a 12% reduction in mortality risk. When participants were divided into fitness quintiles, the most fit group had a 67% lower mortality risk compared to the least fit. Even modest improvements — moving from least fit to low-fit — reduced risk by 24%. The dose-response relationship was consistent and graded, with no apparent ceiling effect.
These protective associations remained robust after adjusting for comorbidities and medications, and they held equally across age groups, racial backgrounds, and both sexes. This consistency strengthens confidence that CRF itself — not confounding lifestyle factors — is driving the survival benefit.
The clinical implications are significant. CRF is modifiable through exercise, meaning clinicians have a concrete, scalable intervention to offer CKD patients. The authors advocate for integrating fitness assessment and exercise prescription into standard CKD care. One caveat: the cohort was predominantly male veterans, which may limit generalizability to women and non-veteran populations.
Key Findings
- Each 1-MET increase in fitness reduced mortality risk by 12% in CKD patients over 16 years.
- The fittest CKD patients had 67% lower mortality risk versus the least-fit group.
- Over 53% of the 45,674 CKD participants died during follow-up, underscoring disease severity.
- Protective fitness-mortality association was consistent across all ages, races, and sexes.
- Even low fitness levels offered meaningful protection compared to the least-fit category (HR 0.76).
Methodology
This prospective cohort study drew 45,674 CKD-diagnosed veterans from the ETHOS database, using objective exercise treadmill testing to measure peak METs. Cox regression models adjusted for comorbidities and medications computed hazard ratios across age- and sex-specific CRF quintiles over a mean 15.9-year follow-up.
Study Limitations
The cohort was predominantly male US veterans, limiting generalizability to women and non-veteran civilian populations. CRF was measured at a single time point, so changes in fitness over time were not captured. Residual confounding from unmeasured lifestyle variables cannot be fully excluded.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.